Measurement of extracellular pH decrease cased by hyperthermiaand drugs on tumor cells.

测量热疗和药物对肿瘤细胞造成的细胞外 pH 值降低。

基本信息

  • 批准号:
    04670682
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1994
  • 项目状态:
    已结题

项目摘要

without affect of metabolic changes the authors measured intratumor pH by using 19-F magnetic resonance spectroscopy (MRS) with a fluorine compound (ZK-150471) on the basis of a curve by pH electrode.Using the 4.7 tesla magnetic resonance apparatus, a fluorine compound that had acid-base equilibrial change and was impermeable within cell membranes was used. The fluorine compound was injected intravenously. The signal was obtained from mouse mammary cancer by creating an experimental tumor on the leg of mice, And the tumors, which were heated with and without hydralazine. The pH evaluated from chemical shift of the fluorine compound. The pH data was obtained from an electrode for reference.The pH of nontreated tumors were 6.94. The p11 decreased to 6.722 at 20 minutes even after 20 minutes of heating.It is possible to measure the extracellular pH by 19F-MRS with the fluorine compound noninvasively in vivo, even after heating.
在不影响代谢变化的情况下,采用含氟化合物(ZK-150471)的19-F磁共振波谱仪(MRS)在pH电极曲线的基础上测定肿瘤内pH值。使用4.7特斯拉磁共振仪,使用一种具有酸碱平衡变化且在细胞膜内不渗透的氟化合物。氟化合物经静脉注射。该信号是通过在小鼠的腿上制造一个实验性肿瘤,从小鼠乳腺癌中获得的,并将肿瘤用和不含肼加热。由氟化合物的化学位移来计算pH值。从电极上获得pH值作为参考。未处理的肿瘤pH值为6.94。即使加热20分钟,p11在20分钟后也下降到6.722。即使在加热后,用氟化合物19F-MRS在体内无创测量细胞外pH值也是可能的。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasushi Itagaki: "Rule of intracellular calcium concentration on tumor cell death from hyperthermia" Oncology Report. 5. 139-141 (1998)
Yasushi Itagaki:“细胞内钙浓度对肿瘤细胞因高温死亡的规则”肿瘤学报告。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshizumi Aoki: "Measurement of intratumor pH by pH indicator used in 19F-magnetic resonance spectroscopy-Measurement of extra cellular pH decrease caused by hyperthermia conbined with hydralazin." InvestigaTive Radiology. 31. 680-689 (1996)
Yoshizumi Aoki:“通过 19F 磁共振波谱法中使用的 pH 指示剂测量肿瘤内 pH 值 - 测量与肼屈嗪相结合的热疗引起的细胞外 pH 值降低。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Norihiko Kitada, Kiyoshi Akagi, Yoshimasa Tanaka, Bernnardd Fritz Zieroth.: "Evaluation of thermal damage hyperthermia on murine experimental tumor by 31P-NMR spectroscopy -Correlation between ATP and growth delays" J.of Radiat.Res. 138. 65-73 (1994)
Norihiko Kitada、Kiyoshi Akagi、Yoshimasa Tanaka、Bernnardd Fritz Zieroth.:“通过 31P-NMR 光谱评估小鼠实验肿瘤热损伤热损伤 - ATP 与生长延迟之间的相关性”J.of Radiat.Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Norihiko Kitada: "Evaluation of thermal damage hyperthermia on murine experimental tumor by 31P-NMR spectroscopy-Correlation between ATP and growth dalays." J of Radiat.Res.138. 65-73 (1994)
Norihiko Kitada:“通过 31P-NMR 光谱评估小鼠实验肿瘤的热损伤热疗 - ATP 与生长延迟之间的相关性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takuro Nishida, Kiyoshi Akagi, Yoshimasa Tanaka: "Correlation between cell killing effect and cell membrane potential after heat treatment : analysis using fluorescent dye and flow cytometry" Int.J.Hyperthermia. 13. 227-234 (1997)
Takuro Nishida、Kiyoshi Akagi、Yoshimasa Tanaka:“热处理后细胞杀伤效果与细胞膜电位之间的相关性:使用荧光染料和流式细胞术进行分析”Int.J.Hyperthermia。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANAKA Yoshimasa其他文献

TANAKA Yoshimasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANAKA Yoshimasa', 18)}}的其他基金

Development of cell preparations and high/low molecular-weight therapeutics that exhibit synergistic effects with PD-1 immune checkpoint antibodies
开发与PD-1免疫检查点抗体具有协同作用的细胞制剂和高/低分子量治疗剂
  • 批准号:
    16K08844
  • 财政年份:
    2016
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analyses of interaction between IL-18-induced helper NK cells and cytotoxic gamma delta T cells
IL-18 诱导的辅助 NK 细胞与细胞毒性 γ δ T 细胞之间相互作用的分析
  • 批准号:
    24590581
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural analysis of costimulatory molecules expressed on human γδ T cells
人γδ T细胞表达的共刺激分子的结构分析
  • 批准号:
    20590489
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on generation mechanism of substorm by using high-resolution auroral data
利用高分辨率极光资料研究亚暴发生机制
  • 批准号:
    19740307
  • 财政年份:
    2007
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Identification of tumor antigens by the use of human γδ TCR tetramers
利用人γδ TCR四聚体鉴定肿瘤抗原
  • 批准号:
    18590470
  • 财政年份:
    2006
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of mechanism for nonpeptide antigen recognition by structural determination of mutated human γδ T cell receptor
通过突变人γδ T细胞受体的结构测定分析非肽抗原识别机制
  • 批准号:
    16590402
  • 财政年份:
    2004
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pattern recognition by human γδ T cells and innate immunity.
人类 γδ T 细胞的模式识别和先天免疫。
  • 批准号:
    12670299
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhacement of the effects of an angiogenesis inhibitor on murine tumors by hyperthermia
通过热疗增强血管生成抑制剂对小鼠肿瘤的作用
  • 批准号:
    07671033
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles of DNA topoisomerase II in the development of the cellular slime molds.
DNA 拓扑异构酶 II 在细胞粘菌发育中的作用。
  • 批准号:
    02640518
  • 财政年份:
    1990
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Measurement of pH in tumor tissue by 31P-MRS and microelectrode after glucose injection.
注射葡萄糖后用 31P-MRS 和微电极测量肿瘤组织的 pH 值。
  • 批准号:
    01570597
  • 财政年份:
    1989
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
剖析肿瘤细胞免疫 TME 轴,以确定可增强 GBM 免疫治疗的治疗上可操作的漏洞
  • 批准号:
    10743534
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
An innovative telomerase-targeted, circulating tumor cell assay for monitoring NSCLC treated with radiation and immunotherapy
一种创新的端粒酶靶向循环肿瘤细胞检测方法,用于监测接受放射和免疫疗法治疗的非小细胞肺癌
  • 批准号:
    10546634
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Label-free volumetric microscopy for visualizing intracellular motility of tumor cell culture
用于可视化肿瘤细胞培养物细胞内运动的无标记体积显微镜
  • 批准号:
    22KF0058
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
  • 批准号:
    10734324
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Mechanisms of tumor cell clustering in breast cancer metastasis
肿瘤细胞聚集在乳腺癌转移中的机制
  • 批准号:
    10744976
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
SBIR Phase I: Advanced microfluidic systems enabling development of novel circulating tumor cell diagnostics
SBIR 第一阶段:先进的微流体系统能够开发新型循环肿瘤细胞诊断
  • 批准号:
    2234009
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Standard Grant
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
  • 批准号:
    10651105
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
The role of tumor cell-of-origin-specific PDL1 on tumorigenesis and tumor progression
肿瘤细胞源特异性PDL1在肿瘤发生和进展中的作用
  • 批准号:
    10679453
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Tumor cell instrinsic DNA damage signaling to the immune response
肿瘤细胞内在 DNA 损伤向免疫反应发出信号
  • 批准号:
    10626282
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了